AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO, Heiner Dreismann, Ph.D., to Its Board of Directors
3/27/2013 10:58:50 AM
More...
|
AdvanDx, Inc. Adds Enterococcal Bacteremia Assay to U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID) Platform
1/10/2013 9:12:10 AM
More...
|
AdvanDx, Inc. Announces U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID), the First Molecular Test to Enable Reporting of Pathogen Identification at the Time of Gram Stain Results From Positive Blood Cultures
9/10/2012 9:29:48 AM
More...
|
AdvanDx, Inc. to Unveil QuickFISH™ (20 Min. Pathogen ID) at ECCMID 2012
3/15/2012 10:44:46 AM
More...
|
AdvanDx, Inc. Release: New Study Shows PNA FISH(R) Test Reporting Dramatically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections
10/13/2011 10:55:05 AM
More...
|
AdvanDx, Inc. Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
1/18/2011 6:34:29 AM
More...
|
AdvanDx, Inc. Launches GNR Traffic Light(TM) PNA FISH(R) in Europe
8/12/2010 11:41:04 AM
More...
|
AdvanDx, Inc. Launches GNR Traffic Light(TM) PNA FISH(R) in Europe
8/12/2010 9:19:11 AM
More...
|
AdvanDx, Inc. Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light(R) PNA FISH(R)
7/29/2010 6:37:30 AM
More...
|
AdvanDx, Inc. to Offer BinaxNOW(R) PBP2a Test for Rapid Detection of PBP2a in Methicillin-Resistant Staphylococcus aureus (MRSA)
5/24/2010 9:03:34 AM
More...
|
|